Clinical Trial Update: FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating FLO (5-fluorouracil, leucovorin, oxaliplatin) with or without Pazopanib as first-line therapy for advanced gastric cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Pazopanib (Pazopanib)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Advanced Gastric Cancer | Phase 2 | Status: COMPLETED